Chlamydia pneumoniae, an obligate intracellular pathogen, is well-known as etiological agent of acute respiratory infections; the repeated or prolonged exposure to chlamydial antigens may promote the persistence of C. pneumoniae in the respiratory tract leading to chronic diseases, such as chronic obstructive pulmonary disease and asthma. The predilection of C. pneumoniae to cause respiratory tract infections combined with its persistent nature suggest that it might play a role in lung cancer. The aim of our study is to evaluate the involvement of C. pneumoniae in pathogenesis of lung cancer. We therefore investigated the presence of C. pneumoniae DNA in tumor lung tissues by using real-time PCR assay. Simultaneously, tumor and healthy tissues from the same patient with primary carcinoma lung were analyzed. C. pneumoniae DNA was not detected in a single lung tumor tissue by means of an highly sensitive, and specific real-time PCR assay based on FRET hybridization probes. In conclusion, this study does not support the involvement of C. pneumoniae in the pathogenesis of lung cancer, suggesting that further investigations are needed to clarify other potential causative factors for the development of this malignancy.
HahnDL. Chlamydia pneumoniae, asthma, and COPD: what is the evidence?Ann Allergy Asthma Immunol1999; 83:271–78.
3.
SriramSLjunggren-RoseAYaoSYWhetsellWOJr. Detection of chlamydial bodies and antigens in the central nervous system of patients with multiple sclerosis. J Infect Dis2005; 192:1219–28.
4.
SessaRSchiavoniGBordelloGZagagliaCMarinelliFdel PianoMPozzilliC. Real time PCR for detection of Chlamydophila pneumoniae in peripheral blood mononuclear cells of patients with multiple sclerosis. J Neurol2007; 254(9):1293–95.
5.
BahnBJAppeltDM. Role of infection in Alzheimer's disease. J Am Osteopath Assoc2001; 101:S 1–6.
6.
SessaRDi PietroMSchiavoniGSantinoICiprianiPRomanoSPencoMdel PianoM. Prevalence of Chlamydia pneumoniae in peripheral blood mononuclear cells in Italian patients with acute ischaemic heart disease. Atherosclerosis2001; 159(2):521–25.
7.
BomanJHammerschlagMR. Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studies. Clin Microbiol Rev2002; 15:1–20.
8.
LittmanAJJacksonLAVaughanTL. Chlamydia pneumoniae and lung cancer: epidemiologic evidence. Cancer Epidemiol Biomarkers Prev2005; 14:773–78.
9.
HoganRJMathewsSAMukhopadhyaySSummersgillJTTimmsP. Chlamydial persistence: beyond the biphasic paradigm. Infect Immun2004; 72:1843–55.
10.
LaurilaALAnttilaTLääräEBloiguAVirtamoJAlbanesDLeinonenMSaikkuP. Serological evidence of an association between Chlamydia pneumoniae infection and lung cancer. Int J Cancer1997; 74:31–4.
11.
StrattonCW. Association of Chlamydia pneumoniae with chronic human diseases. AIDIEX2000; 18:49–55.
12.
LittmanA JThornquistMDWhiteEJacksonLAGoodmanGEVaughanTL. Prior lung disease and risk of lung cancer in a large prospective study. Cancer Causes Control2004; 15(8):819–27.
13.
RedeckeVDalhoffKBohnetSBraunJMaassM. Interaction of Chlamydia pneumoniae and human alveolar macrophages: infection and inflammatory response. Am J Respir Cell Mol Biol1998; 19(5):721–27.
14.
Preston-MartinSPikeMCRossRKJonesPAHendersonBE. Increased cell division as a cause of human cancer. Cancer Res1990; 50:7415–21.
15.
KoyiHBrandénEGnarpeJGnarpeHArnholmBHillerdalG. Chlamydia pneumoniae may be associated with lung cancer. Preliminary report on a seroepidemiological study. APMIS1999; 107(9):828–32.
16.
JacksonLAWangSPNazar-StewartVGraystonJTVaughanTL. Association of Chlamydia pneumoniae immunoglobulin A seropositivity and risk of lung cancer. Cancer Epidemiol Biomarkers Prev2000; 9:1263–66.
17.
KoyiHBrandénEGnarpeJGnarpeHSteenB. An association between chronic infection with Chlamydia pneumoniae and lung cancer. A prospective 2-year study. APMIS2001; 109(9):572–80.
18.
AnttilaTKoskelaPLeinonenMLaukkanenPHakulinenTLehtinenMPukkalaEPaavonenJSaikkuP. Chlamydia pneumoniae infection and the risk of female early-onset lung cancer. Int J Cancer2003; 107:681–82.
19.
KocazeybekB. Chronic Chlamydophila pneumoniae infection in lung cancer, a risk factor: a case-control study. J Med Microbiol2003; 52:721–26.
20.
LittmanAJWhiteEJacksonLAThornquistMDGaydosCAGoodmanGEVaughanTL. Chlamydia pneumoniae infection and risk of lung cancer. Cancer Epidemiol Biomarkers Prev2004; 13:1624–30.
21.
SaikkuPLeinonenMMattilaKEkmanMRNieminenMSMäkeläPHHuttunenJKValtonenV. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet1988; 2:983–86.
22.
RomanoSFratiniSDi PietroMSchiavoniGNicolettiMChiarottiFDel PianoMPencoMSessaR. Chlamydia pneumoniae infection in patients with acute coronary syndrome: a clinical and serological 1-year follow-up. Int J Immunopathol Pharmacol2004; 17:209–18.
23.
DowellSFPeelingRWBomanJCarloneGMFieldsBSGuarnerJHammerschlagMRJacksonLAKuoCCMaassMMessmerTOTalkingtonDFTondellaMLZakiSR: C. pneumoniae Workshop Participants. Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clin Infect Dis2001; 33:492–503.
24.
SessaRDi PietroMSchiavoniGSantinoIBenedetti-ValentiniFPernaRRomanoSdel PianoM. Chlamydia pneumoniae DNA in patients with symptomatic carotid atherosclerotic disease. J Vasc Surg2003; 37(5):1027–31.
25.
SessaRDi PietroMSchiavoniGNicolettiMSodaGNardoniSBoscoDSantinoICiprianiPDel PianoM. Detection of Chlamydia pneumoniae in atherosclerotic coronary arteries. Int J Immunopathol Pharmacol2004; 17:301–06.
26.
SessaRSchiavoniGDi PietroMPetruccaACiprianiPPuopoloMZagagliaCFalluccaSDel PianoM. Chlamydia pneumoniae in PBMC: reproducibility of the OMPA nested touchdown PCR. Int J Immunopathol Pharmacol2005; 18:113–20.
27.
SessaRDi PietroMSchiavoniGGaldieroMCiprianiPRomanoSZagagliaCSantinoIFaccilongoSDel PianoM. Chlamydia pneumoniae in asymptomatic carotid atherosclerosis. Int J Immunopathol Pharmacol2006; 19:111–18.
28.
SessaRDi PietroMSchiavoniGPetruccaACiprianiPZagagliaCNicolettiMSantinoIdel PianoM. Measurement of Chlamydia pneumoniae bacterial load in peripheral blood mononuclear cells may be helpful to assess the state of chlamydial infection in patients with carotid atherosclerotic disease. Atherosclerosis2007; 195:224–30.
